Research

April 25, 2023

COVID alters respiratory microbiota

COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.

By Leigh MacMillan
A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.
April 24, 2023

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

By Nancy Humphrey
April 24, 2023

Novel drugs have potential for treating tuberculosis

Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.

By Leigh MacMillan
April 20, 2023

Overactive bladder and anxiety

Anxiety and psychological stress impact hypersensitivity mechanisms in women that could contribute to overactive bladder — a frequent and sudden urge to urinate that is difficult to control.

By Sarah E. Glass
April 20, 2023

Genetics and chronic pain

Polygenic risk scores — scores that reflect the influence of common genetic variants — could be used to predict the likelihood of developing chronic overlapping pain conditions and guide biomarker and targeted prevention efforts.

By Bill Snyder
From left, Xiang Ye, PhD, Suba Rajendren, PhD, Antiana Richardson, and John Karijolich, PhD, are studying how the cancer-causing virus KSHV commandeers host gene expression and regulatory machinery.
April 20, 2023

Study details RNA editing in virus-infected cancer cells

Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection.

By Leigh MacMillan
April 20, 2023

Malin receives a Vanderbilt distinguished service award

Bradley Malin, PhD, has received one of Vanderbilt University’s top honors, the Alexander Heard Distinguished Service Professor Award.
By Bill Snyder
April 20, 2023

Pharmacology research symposium set for April 28

Researchers from as far away as Brisbane, Australia, and Bangkok, Thailand, will participate in a scientific symposium at Vanderbilt University Medical Center on April 28 honoring the memory of the late Al Reynolds, PhD, professor of Pharmacology, emeritus, who died last year.
By Bill Snyder
April 19, 2023

Four elected to the American Academy of Arts & Sciences

Four Vanderbilt University faculty members were recently elected to the American Academy of Arts & Sciences.
By Bill Snyder
April 13, 2023

Low-professionalism residents later draw higher patient complaints: study

A Vanderbilt study finds a strong association between lower ratings for interpersonal communication skills among medical residents in their last year of training and greater likelihood of unsolicited patient complaints among doctors during their first year of employment after training.
By Paul Govern
April 12, 2023

Research identifies new target that may prevent blood cancer

An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer.
By Bill Snyder
April 11, 2023

VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.
By Nancy Humphrey
April 11, 2023

COVID on Twitter: town vs. country

A natural language processing analysis of 407 million tweets from May 2020 to January 2022 captures the rural-urban divide regarding COVID-19.
By Paul Govern